Peter, B <br/><br/>
Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells.  [electronic resource] 

 -  Leukemia  04 2018 
 - 1016-1022 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2017.338  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Animals<br/>Apoptosis--drug effects<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line, Tumor<br/>Dasatinib--pharmacology<br/>Dogs<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Synergism<br/>Female<br/>G2 Phase Cell Cycle Checkpoints--drug effects<br/>Humans<br/>Leukemia, Mast-Cell--drug therapy<br/>Male<br/>Mast Cells--drug effects<br/>Mastocytosis, Systemic--drug therapy<br/>Middle Aged<br/>Norbornanes--pharmacology<br/>Phosphorylation--drug effects<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-kit--metabolism<br/>Pyrimidines--pharmacology<br/>STAT5 Transcription Factor--metabolism<br/>Staurosporine--analogs & derivatives<br/>Tumor Suppressor Proteins--metabolism<br/>Young Adult